Literature DB >> 17174599

Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry.

Gaetano M De Ferrari1, Catherine Klersy, Paolo Ferrero, Cecilia Fantoni, Diego Salerno-Uriarte, Lorenzo Manca, Paolo Devecchi, Giulio Molon, Miriam Revera, Antonio Curnis, Simona Sarzi Braga, Francesco Accardi, Jorge A Salerno-Uriarte.   

Abstract

BACKGROUND: Estimates of the prevalence of atrial fibrillation (AF) in heart failure (HF) originate from patients enrolled in clinical trials. AIMS: To assess the prevalence and clinical correlates of AF among HF patients in everyday clinical practice from HF patients screened for the T-wave ALternans in Patients with Heart fAilure (ALPHA) study; to investigate the correlation between AF and functional status. METHODS AND
RESULTS: Consecutive patients (N=3513) seen at nine Heart Failure Clinics were studied; 21.4% were in AF. AF prevalence was greater with increasing age (OR 1.04/year, p<0.001) in non-ischaemic cardiomyopathy (OR 2.34, p<0.001) and with increasing NYHA class (p<0.0001). Multiple logistic regression predictors of AF were age >70 years (OR 2.35), NYHA class II III or IV vs class I (OR 1.8, 4.4 and 3.1) and non-ischaemic cardiomyopathy (OR 3.2). A logistic model indicated that AF was associated with a 2.5 OR of being in NYHA class III-IV vs I-II while accounting for age, gender, left ventricular ejection fraction (LVEF), and aetiology of HF.
CONCLUSIONS: The prevalence of AF in HF patients exceeds 20%, and increases with age and functional class. The presence of AF leads to a more severe NYHA class, indicating that AF contributes to the severity of heart failure.

Entities:  

Mesh:

Year:  2006        PMID: 17174599     DOI: 10.1016/j.ejheart.2006.10.021

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  25 in total

Review 1.  T-wave alternans testing for ventricular arrhythmias.

Authors:  Sanjiv M Narayan
Journal:  Prog Cardiovasc Dis       Date:  2008 Sep-Oct       Impact factor: 8.194

2.  Kinetics of left ventricular rotation during exercise and its relation to exercise tolerance in atrial fibrillation: assessment by two-dimensional speckle tracking echocardiography.

Authors:  Kosuke Uchida; Yasuaki Wada; Toru Ariyoshi; Shinichi Okuda; Wakako Murakami; Takeki Myoren; Noriko Harada; Takeshi Yamamoto; Takeshi Ueyama; Nobuaki Tanaka; Masafumi Yano
Journal:  J Echocardiogr       Date:  2014-02-11

Review 3.  Atrial fibrillation in congestive heart failure.

Authors:  Steven A Lubitz; Emelia J Benjamin; Patrick T Ellinor
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

4.  Ranolazine versus amiodarone for prevention of postoperative atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Future Cardiol       Date:  2011-11

Review 5.  Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis.

Authors:  Paul L Hess; Kevin P Jackson; Vic Hasselblad; Sana M Al-Khatib
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

6.  Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial.

Authors:  Shunichi Homma; John L P Thompson; Alexandra R Sanford; Douglas L Mann; Ralph L Sacco; Bruce Levin; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; Susan Graham; J P Mohr; Barry M Massie; Arthur J Labovitz; Marco R Di Tullio; André P Gabriel; Gregory Y H Lip; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker
Journal:  Circ Heart Fail       Date:  2013-07-23       Impact factor: 8.790

7.  Atrial fibrillation in heart failure: The sword of Damocles revisited.

Authors:  Muhammad A Khan; Fozia Ahmed; Ludwig Neyses; Mamas A Mamas
Journal:  World J Cardiol       Date:  2013-07-26

8.  Noninvasive detection of left-ventricular systolic dysfunction by acoustic cardiography in atrial fibrillation.

Authors:  Roger Dillier; Richard Kobza; Susanne Erne; Michel Zuber; Patricia Arand; Paul Erne
Journal:  Cardiol Res Pract       Date:  2010-10-17       Impact factor: 1.866

9.  Atrial fibrillation ablation and heart failure.

Authors:  Jonathan Man; Francis E Marchlinski
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

Review 10.  The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.

Authors:  Yutao Guo; Gregory Y H Lip; Stavros Apostolakis
Journal:  J Cardiovasc Transl Res       Date:  2012-12-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.